STERIS plc (STE)
NYSE: STE · Real-Time Price · USD
215.67
+5.07 (2.41%)
Jun 26, 2026, 4:00 PM EDT - Market closed
STERIS Employees
STERIS had 17,937 employees as of March 31, 2026. The number of employees increased by 150 or 0.84% compared to the previous year.
Employees
17,937
Change (1Y)
150
Growth (1Y)
0.84%
Revenue / Employee
$330,930
Profits / Employee
$43,614
Market Cap
21.02B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 17,937 | 150 | 0.84% |
| Mar 31, 2025 | 17,787 | -392 | -2.16% |
| Mar 31, 2024 | 18,179 | 1,079 | 6.31% |
| Mar 31, 2023 | 17,100 | 678 | 4.13% |
| Mar 31, 2022 | 16,422 | 3,652 | 28.60% |
| Mar 31, 2021 | 12,770 | 411 | 3.33% |
| Mar 31, 2020 | 12,359 | 359 | 2.99% |
| Mar 31, 2019 | 12,000 | 0 | - |
| Mar 31, 2018 | 12,000 | 0 | - |
| Mar 31, 2017 | 12,000 | -2,000 | -14.29% |
| Mar 31, 2016 | 14,000 | 6,400 | 84.21% |
| Mar 31, 2015 | 7,600 | 1,600 | 26.67% |
| Mar 31, 2014 | 6,000 | 0 | - |
| Mar 31, 2013 | 6,000 | 1,000 | 20.00% |
| Mar 31, 2012 | 5,000 | 0 | - |
| Mar 31, 2011 | 5,000 | 0 | - |
| Mar 31, 2010 | 5,000 | 0 | - |
| Mar 31, 2009 | 5,000 | -300 | -5.66% |
| Mar 31, 2008 | 5,300 | 200 | 3.92% |
| Mar 31, 2007 | 5,100 | 0 | - |
| Mar 31, 2006 | 5,100 | -150 | -2.86% |
| Mar 31, 2005 | 5,250 | 150 | 2.94% |
| Mar 31, 2004 | 5,100 | 0 | - |
| Mar 31, 2003 | 5,100 | 604 | 13.43% |
| Mar 31, 2002 | 4,496 | -91 | -1.98% |
| Mar 31, 2001 | 4,587 | -223 | -4.64% |
| Mar 31, 2000 | 4,810 | 66 | 1.39% |
| Mar 31, 1999 | 4,744 | 244 | 5.42% |
| Mar 31, 1998 | 4,500 | 500 | 12.50% |
| Mar 31, 1997 | 4,000 | 3,440 | 614.29% |
| Mar 31, 1996 | 560 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Koninklijke Philips | 65,340 |
| GE HealthCare Technologies | 54,000 |
| Zimmer Biomet Holdings | 17,000 |
| Smith & Nephew | 16,988 |
| Edwards Lifesciences | 16,000 |
| DexCom | 11,100 |
| Bruker | 11,085 |
| Globus Medical | 6,000 |
STE News
- 16 days ago - STERIS Proxy statement: Proxy filing - Filings
- 16 days ago - STERIS Proxy statement: Proxy filing - Filings
- 6 weeks ago - Steris price target lowered to $269 from $291 at KeyBanc - TheFly
- 6 weeks ago - STERIS Earnings Call Transcript: Q4 2026 - Transcripts
- 6 weeks ago - STERIS Earnings release: Q4 2026 - Filings
- 6 weeks ago - STERIS Annual report: Q4 2026 - Filings
- 6 weeks ago - STERIS Slides: Investor presentation - Filings
- 6 weeks ago - Steris reports Q4 adjusted EPS $2.83, consensus $2.85 - TheFly